NM_001122772.3:c.3187C>G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001122772.3(AGAP2):​c.3187C>G​(p.Gln1063Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000207 in 1,446,208 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

AGAP2
NM_001122772.3 missense

Scores

1
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.888

Publications

0 publications found
Variant links:
Genes affected
AGAP2 (HGNC:16921): (ArfGAP with GTPase domain, ankyrin repeat and PH domain 2) The protein encoded by this gene belongs to the centaurin gamma-like family. It mediates anti-apoptotic effects of nerve growth factor by activating nuclear phosphoinositide 3-kinase. It is overexpressed in cancer cells, and promotes cancer cell invasion. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]
AGAP2-AS1 (HGNC:48633): (AGAP2 antisense RNA 1) Biomarker of lung non-small cell carcinoma; malignant astrocytoma; and stomach cancer. [provided by Alliance of Genome Resources, Apr 2022]
OS9 (HGNC:16994): (OS9 endoplasmic reticulum lectin) This gene encodes a protein that is highly expressed in osteosarcomas. This protein binds to the hypoxia-inducible factor 1 (HIF-1), a key regulator of the hypoxic response and angiogenesis, and promotes the degradation of one of its subunits. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.13922274).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGAP2NM_001122772.3 linkc.3187C>G p.Gln1063Glu missense_variant Exon 18 of 19 ENST00000547588.6 NP_001116244.1 Q99490F8VVT9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGAP2ENST00000547588.6 linkc.3187C>G p.Gln1063Glu missense_variant Exon 18 of 19 1 NM_001122772.3 ENSP00000449241.1 F8VVT9

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000207
AC:
3
AN:
1446208
Hom.:
0
Cov.:
33
AF XY:
0.00000139
AC XY:
1
AN XY:
718246
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33356
American (AMR)
AF:
0.00
AC:
0
AN:
41088
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25726
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84470
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50942
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5744
European-Non Finnish (NFE)
AF:
0.00000271
AC:
3
AN:
1105844
Other (OTH)
AF:
0.00
AC:
0
AN:
59864
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 02, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.3187C>G (p.Q1063E) alteration is located in exon 18 (coding exon 18) of the AGAP2 gene. This alteration results from a C to G substitution at nucleotide position 3187, causing the glutamine (Q) at amino acid position 1063 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
18
DANN
Benign
0.95
Eigen
Benign
-0.44
Eigen_PC
Benign
-0.35
FATHMM_MKL
Benign
0.099
N
LIST_S2
Benign
0.74
T;T
M_CAP
Benign
0.030
D
MetaRNN
Benign
0.14
T;T
MetaSVM
Benign
-0.98
T
PhyloP100
0.89
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-0.38
N;N
REVEL
Benign
0.082
Sift
Benign
0.28
T;T
Sift4G
Benign
0.27
T;T
Polyphen
0.24
B;B
Vest4
0.17
MutPred
0.50
.;Loss of helix (P = 0.2271);
MVP
0.50
MPC
2.1
ClinPred
0.22
T
GERP RS
2.8
gMVP
0.75
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1555197772; hg19: chr12-58120906; API